Tag: #Global Trends

The American pharmaceutical giant, Eli Lilly, has designated Huntsville, Alabama, as the location for its third manufacturing facility dedicated to... Read more

Relation Therapeutics has announced the formation of a multi-program, strategic alliance with Novartis with the aim of accelerating the development... Read more

Licensing Agreement Details Pfizer, the U.S.-based pharmaceutical manufacturer, has signed an exclusive licensing deal with Yao Pharma—a subsidiary of Fosun... Read more

Relation Therapeutics has announced the formation of a multi-program, strategic alliance with Novartis with the aim of accelerating the development... Read more

On December 9, 2025, a major pharmaceutical corporation based in New York announced it had entered into an exclusive global... Read more

(ASH Congress) – AstraZeneca (AZ) announced positive clinical data for its leading cell therapy candidate, AZD0120 (formerly GC012F), for the... Read more

The pharmaceutical companies Crescent Biopharma (US-based) and Kelun-Biotech (China-based) have announced a strategic partnership to exchange licensing rights for two... Read more

(ORLANDO) – At an American Society of Hematology (ASH) meeting, the pharmaceutical company Eli Lillypresented results from a critical head-to-head... Read more

Alexion Pharmaceuticals, the rare disease unit of AstraZeneca, has expanded its partnership with biotech company Neurimmune by licensing a second... Read more